None listed
Conditions
Interventions
Intervention1: Sery melt up makeup remover water: Take approximately 10 - 15 drops of Product on cleansing
pad. Swab the product gently on whole face including the eye area (upper and lower eye
lids,
Sponsors
SERY COSMETICS LLP
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subject is having valid proof of identity and age. 2. Subject with skin photo type III to V. 3. Skin is healthy (free of eczema, wounds, inflammatory scar). 4. Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up) 5. Female Subjects in the age group of 18 to 55. 6. Subjects representing varied skin types (representation of all 4 skin types ââ?¬â?? Oily, Normal, Dry and combination) 7. Subjects representing varied eye conditions (representation of Normal Condition, 8. Sensitive Condition, and Contact Lens Users). 9. Subject Habitual of applying makeup. 10. Subject Habitual waterproof make up. 11. Subjects ready to follow instructions during the study period. 12. Subjects willing to come for regular follow up visits.
Exclusion criteria
Exclusion criteria: 1. Subject is either pregnant/ planning a pregnancy, or lactating. 2. Subject having known history or present condition of allergic response to any cosmetic products (face/eye)/ known or suspected intolerance to cosmetic ingredients including fragrance. 3. Subject having any eye infection or allergy/ extremely sensitive eye condition. 4. Subject having any form of cutaneous disease which may Influence the study result. 5.Previous history of atopy with regards to allergic reactions, irritation or intense discomfort feelings to topical-use products, cosmetics or medication. 6. Any history of significant dermatological diseases or conditions or medical conditions. 7. Presence of open sores, pimples, or cysts at the application site 8. Subject having extremely sensitive eye condition. 9. Subject having ocular problems (stye, chalazion, conjunctivitis). 10. Subject having eye infection or allergy. 11. Participation in another clinical study (including cosmetic/ drug studies) or studies with a similar application site, within 30 days of the screening visit. 12. Any participant who, in the judgment of the Investigator, should not participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ophthalmological and dermatological safety assessment of productTimepoint: Assessment on 0 day, 07 day and 14 day | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactManoj Karwa
Auriga Research Private Limited
Outcome results
None listed